Flerie
Flerie AB is a Swedish life science investment company specializing in active ownership of biotechnology, pharmaceutical, and medtech enterprises. The company manages an investment portfolio targeting commercial-stage drug development, contract development and manufacturing, and pioneering medical technologies. Revenue is generated from capital appreciation of portfolio investments, dividend returns, and milestone royalties from underlying life science holdings. Core end markets serve global healthcare providers, biopharmaceutical companies, clinical trial sponsors, and specialized medical research institutions. Flerie holds an established position in the Nordic life science venture capital sector, backed by an experienced team of industry founders. The company is headquartered in Stockholm, Sweden, and its ordinary shares trade on the Nasdaq Stockholm exchange.
2 of the funds FundTelligence covers report a position in Flerie.
- Legal name
- Flerie AB
- Sector
- Financials
- Country
- Sweden
- Funds holding it
- 2
Funds holding Flerie
- Storebrand Sverige Småbolag Plus — Storebrand · 0.05 % (full portfolio disclosed, October 2026)
- Storebrand Sverige Plus — Storebrand · 0.01 % (full portfolio disclosed, October 2026)